Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.2K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.2K
Volume of Distribution01:20

Volume of Distribution

1.5K
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
1.5K
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

6.9K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
6.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Modeling and Similitude01:12

Modeling and Similitude

682
Scaled modeling is a fundamental technique in engineering, enabling the study of large and complex systems by creating smaller, manageable replicas that recreate critical characteristics of the original. In hydrology and civil infrastructure, for example, scaled models of dams help analyze water flow, turbulence, and pressure. This method allows for accurate predictions of real-world behavior within a controlled environment, significantly reducing the cost and time involved in full-scale...
682

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Metabolic brain disease·2026
Same author

Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan.

Medical physics·2026
Same author

Optimizing energy settings in CdTe, CZT, and Si photon-counting CT for material separation and detection.

Physics in medicine and biology·2026
Same author

Precise Lung Density Quantification with a Physics-based CT Harmonizer.

Radiology. Cardiothoracic imaging·2026
Same author

Utility of the virtual imaging trials methodology for objective characterization of AI systems and training data.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

RLIP76: a versatile ATP-dependent transporter as a pharmacotherapeutic target for epilepsy management.

Inflammopharmacology·2026

相关实验视频

Updated: Feb 27, 2026

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

18.0K

人口分布在现实世界和虚拟幻象人口之间匹配.

Dhrubajyoti Ghosh1, Fakrul Tushar2, Lavsen Dahal2

  • 1Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

Medical physics
|February 26, 2026
PubMed
概括

新的框架DISTINCT将虚拟和真实患者数据对齐,用于成像试验. 这确保了在不同人群中进行准确的性能评估,提高了虚拟成像试验的可靠性.

关键词:
瓦斯斯坦的距离是瓦斯斯坦的距离人口统计学匹配情况.虚拟临床试验是虚拟的临床试验.

更多相关视频

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

8.1K
Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation
06:53

Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation

Published on: March 1, 2017

13.9K

相关实验视频

Last Updated: Feb 27, 2026

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

18.0K
Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

8.1K
Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation
06:53

Creating Virtual-hand and Virtual-face Illusions to Investigate Self-representation

Published on: March 1, 2017

13.9K

科学领域:

  • 医疗成像医学成像
  • 生物统计学 生物统计学
  • 临床试验 临床试验

背景情况:

  • 虚拟成像试验 (VIT) 为传统的临床试验提供了经济有效的替代方案.
  • 虚拟群体和真实群体之间的人口差异可能会对成像性能评估产生偏见.
  • 未解决的偏见限制了VIT研究结果对不同患者群体的翻译相关性.

研究的目的:

  • 介绍DISTINCT (共变目标对齐的分布式子样本),这是一个统计框架,用于将临床数据集中的人口学子样本与虚拟队列对齐.
  • 实现虚拟成像试验群体与现实世界临床数据之间的强大比较.

主要方法:

  • 在国家肺部查试验 (NLST) 和虚拟数据集 (VLST) 中应用了DISTINCT.
  • 通过使用多维数据库,共同对准连续 (年龄,BMI) 和分类 (性别,种族,种族) 变量.
  • 使用瓦瑟斯坦和科尔摩戈罗夫-斯米尔诺夫距离评估人口相似性.
  • 在对齐的子样本上使用ROC分析评估肺癌风险预测性能和稳定性.

主要成果:

  • DISTINCT确定了9974名与VLST人群相匹配的最大人口统计学一致的NLST子样本.
  • 肺癌风险评分的曲线下面积 (AUC) 估计稳定在6000名参与者左右.
  • 分层分析突出了人口特异性的AUC变化,强调了对共变量调整的需要.

结论:

  • DISTINCT提供了一种统计严格且可扩展的方法,用于在真实和虚拟成像队列之间对准共变量.
  • 该框架适用于各种成像模式,疾病和变化因素.
  • DISTINCT促进了公平和代表性的绩效评估,促进了VIT在研究和协议优化中的整合.